Workpackage 3

IDENTIFICATION OF A NOVEL NON-INVASIVE PREDICTIVE SIGNATURE OF RESPONSE TO IT and DEVELOPMENT OF A NOVEL READY-TO-USE IMMUNOASSAY

LEADING PARTNER

CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...

PARTNERS INVOLVED

ABONNEZ-VOUS
AUX ACTUALITÉS
DU PROGRAMME CONDOR